BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23354040)

  • 1. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
    Lu SJ; Lee VK; Loo SW
    Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
    Yudistiro R; Arisaka Y; Tokue A; Nakajima T
    BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular sarcoidosis: does (18)F-FDG PET/CT have any role?
    Jung RS; Mittal BR; Maturu NV; Kumar R; Bhattacharya A; Gupta D
    Clin Nucl Med; 2014 May; 39(5):464-6. PubMed ID: 24662648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous sarcoidosis evaluated by FDG PET.
    Li Y; Berenji GR
    Clin Nucl Med; 2011 Jul; 36(7):584-6. PubMed ID: 21637067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
    Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
    Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
    Iino M; Iizuka C
    Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge?
    Mapelli P; Mangili G; Picchio M; Rabaiotti E; Gianolli L; Messa C; Candiani M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):314-7. PubMed ID: 23270913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic sialadenitis with marked lymphadenopathy mimicking lymphoma on FDG PET/CT.
    Liu Y
    Clin Nucl Med; 2014 Aug; 39(8):738-9. PubMed ID: 24978334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT for the diagnosis of sarcoidosis in a patient with bilateral inflammatory involvement of the parotid and lacrimal glands (panda sign) and bilateral hilar and mediastinal lymphadenopathy (lambda sign).
    Oksüz MO; Werner MK; Aschoff P; Pfannenberg C
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):603. PubMed ID: 21210116
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical Presentation of Sarcoidosis on ¹⁸F-FDG PET/CT.
    Jolepalem P; McLean KZ; Wong CY
    J Nucl Med Technol; 2014 Jun; 42(2):114-5. PubMed ID: 24627413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT imaging of extensive systemic sarcoidosis with epididymal involvement.
    Aga F; Yamamoto Y; Tanaka K; Ono Y; Dobashi H; Nishiyama Y
    Clin Nucl Med; 2013 Jan; 38(1):63-4. PubMed ID: 23242053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
    Lu Y; Sweiss NJ
    Clin Nucl Med; 2015 Dec; 40(12):973-4. PubMed ID: 26544904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT.
    Rampin L; Musto A; Marzola MC; Tadayyon S; Ferretti A; Chondrogiannis S; Grassetto G; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):190-2. PubMed ID: 23522858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
    Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
    Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
    Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
    Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
    Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
    Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
    Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
    Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
    Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
    Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
    Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.